Browse by People

Collapse authors list.
Campa, D, Pastore, M, Gentiluomo, M, Talar-Wojnarowska, R, Kupcinskas, J, Malecka-Panas, E, Neoptolemos, JP, Niesen, W, Vodicka, P, Delle Fave, G et al (show 51 more authors) , Bueno-de-Mesquita, HB, Gazouli, M, Pacetti, P, Di Leo, M, Ito, H, Klueter, H, Soucek, P, Corbo, V, Yamao, K, Hosono, S, Kaaks, R, Vashist, Y, Gioffreda, D, Strobel, O, Shimizu, Y, Dijk, F, Andriulli, A, Ivanauskas, A, Bugert, P, Tavano, F, Vodickova, L, Zambon, CF, Lovecek, M, Landi, S, Key, TJ, Boggi, U, Pezzilli, R, Jamroziak, K, Mohelnikova-Duchonova, B, Mambrini, A, Bambi, F, Busch, O, Pazienza, V, Valente, R, Theodoropoulos, GE, Hackert, T, Capurso, G, Cavestro, GM, Pasquali, C, Basso, D, Sperti, C, Matsuo, K, Buechler, M, Khaw, K-T, Izbicki, J, Costello, E, Katzke, V, Michalski, C, Stepien, A, Rizzato, C and Canzian, F (2016) Functional single nucleotide polymorphisms within the cyclin-dependent kinase inhibitor 2A/2B region affect pancreatic cancer risk. ONCOTARGET, 7 (35). pp. 57011-57020.